Medical Weight Loss with Mounjaro, Wegovy & Ozempic
Transform your health with breakthrough GLP-1 medications. Clinically proven to help patients lose 15-25% of body weight under expert medical supervision—without surgery.
500+
Patients Treated
15-25%
Average Weight Loss
97%
Patient Satisfaction
A New Era in Medical Weight Loss
GLP-1 receptor agonists represent the most significant advancement in obesity treatment in decades, offering sustainable weight loss through proven biological mechanisms.
Significant Weight Loss
Clinical trials show 15-25% total body weight loss with GLP-1 medications—comparable to surgical outcomes without going under the knife.
Cardiovascular Benefits
Beyond weight loss, these medications reduce heart attack and stroke risk by up to 20% in patients with cardiovascular disease.
Appetite Control
GLP-1 medications work by reducing hunger signals and increasing feelings of fullness, making it easier to maintain a healthy diet.
FDA-Approved Safety
Mounjaro, Wegovy, and Ozempic are rigorously tested and FDA-approved for chronic weight management with established safety profiles.
Simple Weekly Dosing
Once-weekly self-administered injections fit seamlessly into your lifestyle with minimal time commitment required.
Reduced Food Noise
Patients report dramatic reduction in constant thoughts about food and cravings, leading to a healthier relationship with eating.
Our bariatric medicine specialists have extensive experience prescribing and monitoring GLP-1 medications. We provide comprehensive care including medication management, nutritional guidance, and ongoing support for optimal results.
- Board-certified obesity medicine physicians
- Personalized dosing and titration protocols
- Regular monitoring and dose adjustments
Comprehensive health assessment, medical history review, and discussion of your weight loss goals to determine if GLP-1 therapy is right for you.
Based on your health profile, we'll recommend the most appropriate medication (Mounjaro, Wegovy, or Ozempic) and create a personalized treatment plan.
Start with a lower dose and gradually increase over weeks to minimize side effects and optimize your body's response to the medication.
Regular check-ins, dose adjustments, nutritional guidance, and continuous support to ensure you achieve and maintain your weight loss goals.
Medication Options
Mounjaro (Tirzepatide)
Dual GIP/GLP-1 receptor agonist showing highest weight loss in clinical trials—up to 25% body weight reduction.
Wegovy (Semaglutide)
FDA-approved specifically for weight management. Clinical trials show average 15-17% weight loss over 68 weeks.
Ozempic (Semaglutide)
Originally for Type 2 diabetes, also produces significant weight loss. May be prescribed off-label for weight management.
GLP-1 medications are suitable for adults struggling with obesity or weight-related health conditions. Ideal candidates typically meet several of the following criteria:
- BMI of 30+ (obesity)
- BMI of 27+ with weight-related health conditions
- Previous diet and exercise attempts without lasting success
- No history of medullary thyroid cancer
- No personal or family history of MEN 2 syndrome
- Commitment to lifestyle modifications
Ready to Get Started?
Our team will review your medical history, discuss your goals, and determine if GLP-1 medication therapy is the right choice for you—with no obligation.
Average Weight Loss
Patients typically lose 15-25% of their total body weight within 12-18 months of treatment
Improved A1C Levels
Significant improvement in blood sugar control for patients with Type 2 diabetes or prediabetes
Patient Satisfaction
Our patients consistently rate their experience and weight loss outcomes as excellent
FDA Approved
These breakthrough medications have been rigorously tested and approved for weight management
Real Patient Stories
Frequently Asked Questions
What's the difference between Mounjaro, Wegovy, and Ozempic?
All three are injectable GLP-1 medications, but they work slightly differently. Mounjaro (tirzepatide) targets both GIP and GLP-1 receptors and shows the highest weight loss in trials (up to 25%). Wegovy (semaglutide 2.4mg) is FDA-approved specifically for weight loss. Ozempic (semaglutide 1mg) is primarily for Type 2 diabetes but also produces significant weight loss. We’ll recommend the best option based on your health profile and goals.
How much weight can I expect to lose?
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These typically occur when starting or increasing doses and usually improve within a few weeks. Starting with low doses and gradually increasing helps minimize side effects. We’ll work closely with you to manage any symptoms.
What are the common side effects?
GLP-1 medications are typically prescribed for long-term use. Studies show that stopping the medication often leads to weight regain, as these drugs address the biological factors driving obesity. Many patients use them indefinitely, though some may eventually transition to lower maintenance doses or other strategies.
How long do I need to take the medication?
GLP-1 medications are typically prescribed for long-term use. Studies show that stopping the medication often leads to weight regain, as these drugs address the biological factors driving obesity. Many patients use them indefinitely, though some may eventually transition to lower maintenance doses or other strategies.
Is this covered by insurance?
Coverage varies significantly by insurance plan. Many plans cover Ozempic for diabetes but not weight loss. Wegovy coverage for obesity is improving but still inconsistent. Mounjaro coverage depends on whether it’s prescribed for diabetes or weight loss. We can help you navigate insurance options and discuss cash-pay pricing if needed.
Can I take GLP-1 medications if I have diabetes?
Yes! These medications are excellent for patients with Type 2 diabetes. Ozempic and Mounjaro are FDA-approved for diabetes management and provide the added benefit of weight loss. If you’re on other diabetes medications, we may need to adjust them to prevent low blood sugar. Always inform us of all medications you’re taking.
How are the injections administered?
All three medications are self-administered once weekly using a pre-filled pen device. The injection is subcutaneous (just under the skin) in the abdomen, thigh, or upper arm. Most patients find it quick and relatively painless. We’ll train you on proper injection technique during your initial visits.
Who should NOT take these medications?
GLP-1 medications are not recommended for people with personal or family history of medullary thyroid cancer, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or history of pancreatitis. They’re also not suitable during pregnancy or breastfeeding. A thorough medical evaluation ensures these medications are safe for you.